Author:
Kim Yun Gi,Choi Yun Young,Han Kyung-Do,Min Kyongjin,Choi Ha Young,Shim Jaemin,Choi Jong-Il,Kim Young-Hoon
Abstract
AbstractAtrial fibrillation (AF) is associated with various major adverse cardiac events such as ischemic stroke, heart failure, and increased overall mortality. However, its association with lethal ventricular arrhythmias such as ventricular tachycardia (VT), ventricular flutter (VFL), and ventricular fibrillation (VF) is controversial. We conducted this study to determine whether AF can increase the risk of VT, VFL, and VF. We utilized the Korean National Health Insurance Service database for this nationwide population-based study. This study enrolled people who underwent a nationwide health screen in 2009 for whom clinical follow-up data were available until December 2018. Primary outcome endpoint was the occurrence of VT, VFL, or VF in people who were and were not diagnosed with new-onset AF in 2009. We analyzed a total of 9,751,705 people. In 2009, 12,689 people were diagnosed with new-onset AF (AF group). The incidence (events per 1000 person-years of follow-up) of VT, VFL, and VF was 2.472 and 0.282 in the AF and non-AF groups, respectively. After adjustment for covariates, new-onset AF was associated with 4.6-fold increased risk (p < 0.001) of VT, VFL, and VF over 10 years of follow-up. The risk of VT, VFL, and VF was even higher if identification of AF was based on intensified criteria (≥ 2 outpatient records or ≥ 1 inpatient record; hazard ratio = 5.221; p < 0.001). In conclusion, the incidence of VT, VFL, and VF was significantly increased in people with new-onset AF. The potential risk of suffering lethal ventricular arrhythmia in people with AF should be considered in clinical practice.
Funder
National Research Foundation of Korea (NRF) grant funded by the Korea government
Korea University Grant
Korea University Anam Hospital
Publisher
Springer Science and Business Media LLC
Reference36 articles.
1. Lip, G. Y., Tse, H. F. & Lane, D. A. Atrial fibrillation. Lancet 379, 648–661 (2012).
2. Kim, Y. G., Shim, J., Choi, J. I. & Kim, Y. H. Radiofrequency catheter ablation improves the quality of life measured with a short form-36 questionnaire in atrial fibrillation patients: A systematic review and meta-analysis. PLoS ONE 11, e0163755 (2016).
3. Kjerpeseth, L. J. et al. Prevalence and incidence rates of atrial fibrillation in Norway 2004–2014. Heart 107, 201–207 (2021).
4. Dai, H. et al. Global, regional, and national prevalence, incidence, mortality, and risk factors for atrial fibrillation, 1990–2017: Results from the global burden of disease study 2017. Eur. Heart. J. Qual. Care Clin. Outcomes 9, 1–9 (2020).
5. Magnussen, C. et al. Sex differences and similarities in atrial fibrillation epidemiology, risk factors, and mortality in community cohorts: Results from the biomarcare consortium (biomarker for cardiovascular risk assessment in europe). Circulation 136, 1588–1597 (2017).
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献